Boris Labar
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 93
- Hematopoietic Stem Cell Transplantation 52
- Acute Myeloid Leukemia Research 41
- Multiple Myeloma Research and Treatments 15
- Chronic Myeloid Leukemia Treatments 14
- Oncology 37
- Neutropenia and Cancer Infections 12
- Co-authors
- Stefan Suciu (21 shared papers)Petra Muus (17 shared papers)Mirando Mršić (31 shared papers)Igor Aurer (26 shared papers)Théo de Witte (10 shared papers)Ivo Radman (27 shared papers)Dominik Selleslag (8 shared papers)Liliana Baila (3 shared papers)
- Journals
- Blood (12 papers)Annals of Hematology (6 papers)Bone Marrow Transplantation (5 papers)Journal of Clinical Oncology (3 papers)Leukemia Research (2 papers)
- Partner nations
- CroatiaGermanyNetherlands
In The Last Decade
Boris Labar
138 papers receiving 2.2k citations
Boris Labar's Hit Papers
Peers
Comparison fields: 5 of 97
- Hematology 1.4k
- Genetics 344
- Oncology 451
- Public Health, Environmental and Occupational Health 360
- Pathology and Forensic Medicine 182
Countries citing papers authored by Boris Labar
This map shows the geographic impact of Boris Labar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris Labar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris Labar more than expected).
Fields of papers citing papers by Boris Labar
This network shows the impact of papers produced by Boris Labar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris Labar. The network helps show where Boris Labar may publish in the future.
Co-authors
The 25 scholars most cited alongside Boris Labar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 152 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group Hit paper breakdown → | 2011 | 428 |
| 2 | 2008 | 156 | |
| 3 | 2009 | 136 | |
| 4 | Relationship between differing volumes of bone marrow aspirates and their cellular composition. | 1990 | 72 |
| 5 | Prostaglandin E2 for prophylaxis of oral mucositis following BMT. | 1993 | 70 |
| 6 | Allogeneic stem cell transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma for patients | 2004 | 62 |
| 7 | Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. | 1996 | 56 |
| 8 | 2008 | 55 | |
| 9 | 2002 | 46 | |
| 10 | Total body irradiation with or without lung shielding for allogeneic bone marrow transplantation. | 1989 | 45 |
| 11 | 2007 | 42 | |
| 12 | 2011 | 41 | |
| 13 | 2003 | 35 | |
| 14 | 2018 | 35 | |
| 15 | Aberrant glycosylation of Igg heavy chain in multiple myeloma. | 2007 | 33 |
| 16 | 2008 | 28 | |
| 17 | 2011 | 28 | |
| 18 | Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study. | 2002 | 25 |
| 19 | 2009 | 25 | |
| 20 | 1995 | 25 |
About Boris Labar
Boris Labar is a scholar working on Hematology, Oncology, Public Health, Environmental and Occupational Health, Genetics and Molecular Biology, having authored 152 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (52 papers), Acute Myeloid Leukemia Research (41 papers), Acute Lymphoblastic Leukemia research (29 papers), Lymphoma Diagnosis and Treatment (17 papers), Multiple Myeloma Research and Treatments (15 papers), Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Neutropenia and Cancer Infections (12 papers). The work is most often cited by research in Hematology (1.4k citations), Genetics (344 citations), Oncology (451 citations), Public Health, Environmental and Occupational Health (360 citations) and Pathology and Forensic Medicine (182 citations). Boris Labar has collaborated with scholars based in Croatia, Germany and Netherlands. Frequent co-authors include Stefan Suciu, Petra Muus, Mirando Mršić, Igor Aurer, Théo de Witte, Ivo Radman, Dominik Selleslag, Liliana Baila, Dan Nemet and F Beeldens. Their work appears in journals such as Blood, Annals of Hematology, Bone Marrow Transplantation, Journal of Clinical Oncology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.